- $706.91m
- $1.12bn
- $1.06bn
Brief: Enhabit Urges Stockholders To Vote For Co's Nominees At July 25 Annual Meeting
Proxy advisor Glass Lewis advises Enhabit investors to elect three AREX nominees
Brief: ISS Recommends Stockholders Vote “For” A Majority Of Enhabit Home Health & Hospice Director Nominees
ISS suggest Enhabit shareholders elect three AREX Capital nominees to board (updated)
ISS suggest Enhabit shareholders elect three AREX Capital nominees to board
Brief: Enhabit Recommends Stockholders Vote For Enhabit's Director Nominees On Yellow Proxy Card
Arex Capital Management nominates seven directors to Enhabit's board (updated)
Arex Capital Management nominates seven directors to Enhabit's board
Brief: Arex Capital Management Issues Letter To Enhabit Stockholders Regarding The Need For Changes To Board Composition
Advisory: Dated alert on Enhabit strategic review withdrawn
Enhabit Inc reports results for the quarter ended in January - Earnings Summary
Advisory: Alerts on AREX Capital wrongly tagged to multiple companies withdrawn
Brief: Arex Capital Says Are "Disappointed" That Enhabit's Strategic Review Process Concluded Without Sale
AREX Capital to mount board challenge against Enhabit, sources say
U.S. RESEARCH ROUNDUP- Crescent Energy, Rockwell Automation, Transdigm Group
Brief: Enhabit Concludes Review Of Strategic Alternatives
Enhabit Inc expected to post earnings of 4 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Carvana Co, Oracle, Vail Resorts
Enhabit Inc reports results for the quarter ended in December - Earnings Summary